Regenative Labs Highlights Advancements in Post-Surgical Breast Reduction
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
The new program is intended to offer practice partners incentives tied to purchases across its bio serums portfolio.